Tag: peripheral

(HealthDay)—The U.S. Food and Drug Administration on Friday expanded approval for the use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with specific types of peripheral T-cell lymphoma (PTCL). The FDA stated in a press release that this approval is the first for treatment of newly diagnosed PTCL. Adcetris, a monoclonal

PAD affects the blood vessels causing them to narrow, therefore restricting the blood flow to the arms, kidneys, stomach, and most commonly, the legs. An estimated 8.5 million people in the United States have peripheral artery disease, affecting approximately 12-20 percent of Americans over 60. Peripheral artery disease is a major risk factor for heart

A long-term study of patients who received stem cells to treat angiitis-induced critical limb ischemia (AICLI) shows the cells to be both safe and effective. The study, published in Stem Cells Translational Medicine (SCTM), could lead to an option for those who suffer from this serious form of peripheral arterial disease (PAD). AICLI is caused